These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 20056300)

  • 1. Current therapeutic approaches to fungal infections in immunocompromised hematological patients.
    Pagano L; Caira M; Valentini CG; Posteraro B; Fianchi L
    Blood Rev; 2010 Mar; 24(2):51-61. PubMed ID: 20056300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in antifungal prevention and treatment.
    Groll AH; Tragiannidis A
    Semin Hematol; 2009 Jul; 46(3):212-29. PubMed ID: 19549575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary fungal infection with yeasts and pneumocystis in patients with hematological malignancy.
    Pagano L; Caira M; Fianchi L
    Ann Med; 2005; 37(4):259-69. PubMed ID: 16019724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changing strategies for the management of invasive fungal infections.
    Rapp RP
    Pharmacotherapy; 2004 Feb; 24(2 Pt 2):4S-28S; quiz 29S-32S. PubMed ID: 14992487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of mycoses in patients with hematologic disease and cancer -- review of the literature.
    Ruhnke M; Maschmeyer G
    Eur J Med Res; 2002 May; 7(5):227-35. PubMed ID: 12069913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prevention of fungal infections in children and adolescents with cancer].
    Groll AH; Ritter J; Müller FM
    Klin Padiatr; 2001 Sep; 213 Suppl 1():A50-68. PubMed ID: 11577364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of mycoses in surgical patients -- review of the literature.
    Holzheimer RG; Dralle H
    Eur J Med Res; 2002 May; 7(5):200-26. PubMed ID: 12069912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
    Fera MT; La Camera E; De Sarro A
    Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antifungal prophylaxis for invasive mycoses in high risk patients.
    Ullmann AJ; Cornely OA
    Curr Opin Infect Dis; 2006 Dec; 19(6):571-6. PubMed ID: 17075333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry.
    Neofytos D; Horn D; Anaissie E; Steinbach W; Olyaei A; Fishman J; Pfaller M; Chang C; Webster K; Marr K
    Clin Infect Dis; 2009 Feb; 48(3):265-73. PubMed ID: 19115967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal treatment strategies in high risk patients.
    Rüping MJ; Vehreschild JJ; Cornely OA
    Mycoses; 2008 Sep; 51 Suppl 2():46-51. PubMed ID: 18721331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Systemic fungal infections in immunocompromised patients].
    Zupanić-Krmek D; Nemet D
    Acta Med Croatica; 2004; 58(4):251-61. PubMed ID: 15700680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fungal respiratory disease.
    Yao Z; Liao W
    Curr Opin Pulm Med; 2006 May; 12(3):222-7. PubMed ID: 16582678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
    Metcalf SC; Dockrell DH
    J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and therapy of fungal infection in patients with leukemia--new drugs and immunotherapy.
    Anaissie EJ
    Best Pract Res Clin Haematol; 2008 Dec; 21(4):683-90. PubMed ID: 19041608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new era of antifungal therapy.
    Wingard JR; Leather H
    Biol Blood Marrow Transplant; 2004 Feb; 10(2):73-90. PubMed ID: 14750074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of invasive organ mycoses in patients with systemic hematologic diseases].
    Karthaus M; Böhme A
    Wien Med Wochenschr; 2001; 151(3-4):80-8. PubMed ID: 11789423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Posaconazole salvage therapy allows successful allogeneic hematopoietic stem cell transplantation in patients with refractory invasive mold infections.
    Mullane K; Toor AA; Kalnicky C; Rodriguez T; Klein J; Stiff P
    Transpl Infect Dis; 2007 Jun; 9(2):89-96. PubMed ID: 17461992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fungal infections in cancer patients: an escalating problem.
    Samonis G; Bafaloukos D
    In Vivo; 1992; 6(2):183-93. PubMed ID: 1525339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.